Robert Peralta
Overview
Explore the profile of Robert Peralta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huynh P, Saba E, Rivero A, Peralta R, Liang J
Otol Neurotol
. 2024 Aug;
45(8):e566-e569.
PMID: 39142306
Objectives: To evaluate otologic adverse reactions (OARs), including hearing loss (OARs-HL) among patients taking teprotumumab, a new biologic approved for the treatment of active thyroid eye disease, using publicly available...
2.
Gonzalez-Forteza C, Hermosillo de la Torre A, Vacio-Muro M, Peralta R, Wagner F
Bol Med Hosp Infant Mex
. 2018 Feb;
72(2):149-155.
PMID: 29425995
Depression is an important public health problem that requires more and better attention. In the present work we review epidemiologic studies of depression among adolescents in Mexico and discuss strategies...
3.
Johnson J, Nourhani A, Peralta R, McDonald C, Thiesing B, Mann C, et al.
Phys Rev E
. 2017 May;
95(4-1):042609.
PMID: 28505853
We experimentally investigated the self-assembly of chemically active colloidal Janus spheres into dimers. The trans-dimer conformation, in which the two active sites are oriented roughly in opposite directions and the...
4.
Al-Qawasmeh R, Huesca M, Nedunuri V, Peralta R, Wright J, Lee Y, et al.
Bioorg Med Chem Lett
. 2010 May;
20(12):3518-20.
PMID: 20483613
A new series of antimicrobial derivatives [3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole)] have been synthesized with potent activity against strains of Staphylococcus aureus, including methicillin-resistant strains (MRSA). Compound 17 [3-(4,5-bis(4-fluorophenyl)-1H-imidazol-2-yl)-5-bromo-1H-indole], the most active derivative was...
5.
Huesca M, Lock L, Khine A, Viau S, Peralta R, Cukier I, et al.
Mol Cancer Ther
. 2009 Sep;
8(9):2586-96.
PMID: 19755513
ML-133 is a novel small molecule with potent antiproliferative activity, as shown in cancer cell lines and in a human colon tumor xenograft model. ML-133 reduces the concentration of intracellular...
6.
Mahajan A, Sato D, Shiferaw Y, Baher A, Xie L, Peralta R, et al.
Biophys J
. 2007 Dec;
94(2):411-23.
PMID: 18160661
The L-type Ca current (I(Ca,L)), essential for normal cardiac function, also regulates dynamic action potential (AP) properties that promote ventricular fibrillation. Blocking I(Ca,L) can prevent ventricular fibrillation, but only at...
7.
Huesca M, Peralta R, Sauder D, Simor A, McGavin M
J Infect Dis
. 2002 May;
185(9):1285-96.
PMID: 12001046
Epidemic Canadian methicillin-resistant Staphylococcus aureus strain 1 (CMRSA-1) comprises related subtypes that differ in phenotype and prevalence, with subtypes 1A, 1B, and 1D representing 1%, 71%, and 18%, respectively, of...